Preformulation/Formulation Project Initiation Form: Client Information
Preformulation/Formulation Project Initiation Form: Client Information
Preformulation/Formulation Project Initiation Form: Client Information
NATURE OF WORK:
cGMP Method Development GC/MS LC/MS ELISA CE Gel Electrophoresis non cGMP AAA Extractables/Leachables Method Validation Cleaning Validation Method Optimization Method Feasibility Extend to Stability Preformulation Formulation API Characterization Other (please describe)
PRODUCT INFORMATION:
Name of Product: Product Description: (# of strengths / # of lots) Product Matrix DPI Nebulized MDI Nasal Lyophile Solution Suspension Capsule/ Tablet Other (please describe) Finished Dosage Form: Packaging Configuration: Dosage Form Strength: N Excipients: Development Phase Pre-IND I II III FDA Approved Other (please describe)
Placebo included? Y N API: Crystaline: Y N Aqueous Solubility: Y Hydroscopic: Y N Y N Stable: Sensitive to Light: Y PKa Value: Salt Form: Finished Dosage Form:
N Value:
TECHNICAL BACKGROUND:
Physical and Chemical Properties Previous Work at Irvine Special Equipment Needs? Identify ___________________________________________________________________________
1 of 2
SAFETY INFORMATION:
Hazardous Yes No If yes, list type(s): Mass/volume to be sent: Special Handling Requirements: Unknown DEA Controlled No X I II III IV V
QUALITY ASSURANCE:
Full QA Review Peer Review Other: ____________________________________________________________
FINAL REPORT:
Irvine Template Client Template Other: ____________________________________________________________
TECH TRANSFER:
Back to client To Irvine AC Other: ____________________________________________________________
DISPOSAL OF SAMPLES:
Standard (30 days post report): Special Handling (return to client): Attention: _________________________________ Address: _________________________________ _________________________________ Client Shipping Account Number: _____________________
2 of 2